Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Apple
AAPL
|
+$814M |
| 3 |
NVIDIA
NVDA
|
+$700M |
| 4 |
Broadcom
AVGO
|
+$647M |
| 5 |
Shopify
SHOP
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$701M |
| 2 |
Johnson & Johnson
JNJ
|
+$685M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$484M |
| 4 |
Meta Platforms (Facebook)
META
|
+$407M |
| 5 |
HubSpot
HUBS
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.47% |
| 2 | Financials | 12.85% |
| 3 | Industrials | 11.86% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Patriot National Bancorp
PNBK
$136M
| $35.1K | ﹤0.01% |
+23,100
| New | +$62.4K |
|
3677
Nerdy
NRDY
$94.1M
| $34.4K | ﹤0.01% |
21,088
-1,660
| -7% | -$2.65K |
|
3678
Prime Medicine
PRME
$593M
| $33.7K | ﹤0.01% |
13,662
-1,174
| -8% | -$1.81K |
|
3679
SKYX Platforms
SKYX
$165M
| $33.6K | ﹤0.01% |
+32,183
| New | +$38.8K |
|
3680
CytomX Therapeutics
CTMX
$745M
| $32.2K | ﹤0.01% |
+14,171
| New | +$22.8K |
|
3681
Wolfspeed
WOLF
$1.57B
| $31.9K | ﹤0.01% |
79,934
-1,628,977
| -95% | -$3.71M |
|
3682
Caribou Biosciences
CRBU
$164M
| $31.2K | ﹤0.01% |
24,739
-34,235
| -58% | -$33.7K |
|
|
ELPW
3683
Elong Power Holding Ltd
ELPW
$2.73M
| $30.6K | ﹤0.01% |
+1
| New | +$147K |
|
|
HURA
3684
TuHURA Biosciences
HURA
$141M
| $30.1K | ﹤0.01% |
+13,501
| New | +$45.6K |
|
3685
Vivid Seats
SEAT
$85M
| $29.6K | ﹤0.01% |
877
-175
| -17% | -$7.49K |
|
3686
KLX Energy Services
KLXE
$44M
| $29.4K | ﹤0.01% |
15,707
-8,992
| -36% | -$18.7K |
|
3687
Pulmonx
LUNG
$94.1M
| $27.3K | ﹤0.01% |
10,528
-170
| -2% | -$671 |
|
3688
Waldencast
WALD
$174M
| $25.5K | ﹤0.01% |
+10,415
| New | +$26.4K |
|
3689
NET Power
NPWR
$135M
| $25K | ﹤0.01% |
+10,108
| New | +$21.2K |
|
3690
Tevogen Inc. Common Stock
TVGN
$27.5M
| $22.6K | ﹤0.01% |
361
+5
| +1% | +$285 |
|
|
NTCL
3691
NetClass Technology Inc
NTCL
$3.84M
| $22.3K | ﹤0.01% |
+270
| New | +$131K |
|
3692
BRC Inc
BRCC
$229M
| $16.2K | ﹤0.01% |
12,352
+865
| +8% | +$1.6K |
|
3693
Acumen Pharmaceuticals
ABOS
$173M
| – | – |
-127,798
| Closed | -$141K |
|
3694
Achieve Life Sciences
ACHV
$687M
| – | – |
-73,644
| Closed | -$197K |
|
3695
Acrivon Therapeutics
ACRV
$74.9M
| – | – |
-35,315
| Closed | -$71.7K |
|
|
ADAP
3696
DELISTED
Adaptimmune Therapeutics
ADAP
| – | – |
-78,031
| Closed | -$15.4K |
|
|
ADVM
3697
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-49,831
| Closed | -$218K |
|
|
AFB
3698
AllianceBernstein National Municipal Income Fund
AFB
$316M
| – | – |
-36,714
| Closed | -$399K |
|
|
AGEN
3699
Agenus
AGEN
$283M
| – | – |
-58,281
| Closed | -$87.7K |
|
|
AKYA
3700
DELISTED
Akoya BioSciences
AKYA
| – | – |
-45,141
| Closed | -$62.7K |
|
Similar funds
Invesco's Q2 2025 Portfolio in Review
As of Q2 2025, Invesco held 3,922 positions worth $588B, up 11% from $528B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Invesco's Q2 2025 filing shows 165 new, 1,670 increased, 1,835 reduced and 165 closed positions. Its largest new stake was QXO Inc: 27,561,664 shares worth $594M. The largest sale was UnitedHealth, an estimated $701M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2025 buy was QXO Inc: 27,561,664 shares worth $594M.
- Invesco added most to Microsoft in Q2 2025, an estimated $1.45B increase.
- Invesco's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $701M.
- Invesco fully exited Discover Financial Services in Q2 2025, selling an estimated $484M.
- Invesco's ten largest holdings make up 20% of its $588B portfolio in Q2 2025.
- Invesco opened 165 new positions and closed 165 in Q2 2025.
- Invesco's portfolio value rose 11% quarter-over-quarter to $588B.
Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.